Higher titers of some H5N1 and recent human H1N1 and H3N2 influenza viruses in Mv1 Lu vs. MDCK cells
© Hamilton et al; licensee BioMed Central Ltd. 2011
Received: 22 December 2010
Accepted: 11 February 2011
Published: 11 February 2011
The infectivity of influenza A viruses can differ among the various primary cells and continuous cell lines used for such measurements. Over many years, we observed that all things equal, the cytopathic effects caused by influenza A subtype H1N1, H3N2, and H5N1 viruses were often detected earlier in a mink lung epithelial cell line (Mv1 Lu) than in MDCK cells. We asked whether virus yields as measured by the 50% tissue culture infectious dose and plaque forming titer also differed in MDCK and Mv1 Lu cells infected by the same influenza virus subtypes.
The 50% tissue culture infectious dose and plaque forming titer of many influenza A subtype H1N1, H3N2, and H5N1 viruses was higher in Mv1 Lu than in MDCK cells.
The yields of influenza subtype H1N1, H3N2, and H5N1 viruses can be higher in Mv1 Lu cells than in MDCK cells.
The infectivity of influenza viruses can differ among the various primary cells and continuous cell lines used for such measurements [1, 2]. As the term "infectivity" has many meanings in virology, in this manuscript, infectivity is broadly defined as the ability of a virus particle to enter a host cell and form viable progeny virions. Measures of infectivity depend not only on the inherent susceptibility of a particular type of cell for a given influenza virus, but also on the methodology used for infecting the cells [such as the length of time the virus is left in contact with the cells, as the affinity/avidity of a virus for its receptor(s) may vary according to cell type], the quasispecies distribution within a particular influenza virus stock, and other variables.
Accurate viable virus counts are essential for inhalation exposure studies with aerosolized viruses , for correlation of viable count to genome equivalence in level of detection studies, and other relevant work with influenza viruses. Quantitative RT-PCR methods are not suitable, as they do not distinguish between viable and non-viable virus particles. Indeed, infectious influenza virus particles comprise a minor subpopulation of biologically active particles (BAP) within a viral population . The other BAP include interferon suppressing particles [4, 5], defective interfering particles [4, 6], and noninfectious cell-killing particles [4, 7].
Characteristics of MDCK and Mv1 Lu cells
Male and female from fetuses
The acronym Mv1 Lu stems from "Mustela vison (American mink) lung" (now reclassified as Neovison vison). Mink are highly related to ferrets and are susceptible to influenza viruses . We are performing various studies of influenza viruses in domesticated ferrets (Mustela putorius furo), and asked whether Mv1 Lu cells might be advantageous for the isolation and/or enumeration of H5N1 and other influenza viruses in ferret tissue specimens or secretions. An underlying assumption of ours was that influenza viruses in specimens derived from ferrets with active influenza infections would effectively attach, replicate and efficiently produce progeny virions in Mv1 Lu cells. Moreover, we wished to know whether virus yields might differ in MDCK vs Mv1 Lu cells. We learned that the virus yields of many low-passage influenza A virus strains was higher in Mv1 Lu cells than in MDCK cells, even when the virus had not been adapted for growth in ferrets.
1. Validation of cell lines
2. Pandemic H1N1 2009 viruses can be propagated in Mv1 Lu cells
3. Mv1 Lu cells can be used for influenza A virus plaque assays
4. Titration of influenza H5N1 viruses
Titers of egg-grown H5N1 viruses in MDCK and Mv1 LU cells.
Mv1 Lu cells
Log 10 TCID 50 /ml
Log 10 PFU/ml
Log 10 TCID 50 /ml
Log 10 PFU/ml
5. Titration of seasonal and pandemic H1N1 2009 influenza viruses
Titers of egg-grown seasonal and 2009 pandemic influenza viruses in MDCK and Mv1 Lu cellsa.
Mv1 Lu cells
Log 10 TCID 50 /ml
Log 10 PFU/ml
Log 10 TCID 50 /ml
Log 10 PFU/ml
A/Puerto Rico/8/1934 (H1N1)
A/New Caledonia/20/1999 (H1N1)
A/New York/18/2009 (H1N1)
A/Hong Kong/8/1968 (H3N2)
A/New York/55/2004 (H3N2)
As for MDCK cells, Mv1 Lu cells can be used for both influenza A virus TCID50 and plaque assays. And in establishing parameters for the enumeration of various influenza A strains, we observed that higher virus titers were attained for many in Mv1 Lu cells compared to the titer obtained in the more commonly used MDCK cell line. Taken together, it may be advantageous to use Mv1 Lu cells for certain applications, such as for obtaining estimates of a delivered dose of aerosolized influenza virus in inhalation exposure studies , and for the detection of relatively small amounts of infectious influenza virus particles in tissue or secretion specimens.
Though not specifically mentioned in the body of this manuscript, we noted that Mv1 Lu cells must be handled as described (Materials and Methods). When Mv1 Lu cells are maintained confluent for more than 1 week without splitting them for virus titration, variability in the CPE caused by influenza viruses occurs, as reported by Schultz-Cherry et al . In the improperly maintained Mv1 Lu cells, the appearance of CPE is typically delayed compared to MDCK cells, and these Mv1 Lu cells cannot be used for plaque assays.
Materials and methods
MDCK and Mv1 Lu from Diagnostic Hybrids, Inc. were selected for this work. The MDCK cells were obtained at passage 68 and used through passage 78, Mv1 Lu cells at passage 71 and used through passage 88. Both cell lines were cultured as monolayers at 37ºC and 5% CO2. Both cell lines were routinely propagated in either Dulbecco's Modifed Eagle's Medium (DMEM) (Mediatech, Inc., Manassas, VA) or Earle's Minimal Essential Medium (EMEM) (Invitrogen Corp., Carlsbad, CA). Both medium formulations were supplemented with 2 mM L-Alanyl-L-Glutamine (GlutaMAX™, Invitrogen Corp.), antibiotics [PSN; 50μg/ml penicillin, 50 μg/ml streptomycin, 100 μg/ml neomycin (Invitrogen Corp.)], and 10% (v/v) heat-inactivated gamma-irradiated fetal bovine serum (HyClone, Logan, Utah). Sodium pyruvate (Invitrogen Corp.) and non-essential amino acids (Hyclone) were added to EMEM (each at a manufacturer's recommended final concentration of 1×). Prior to virology tests, the following precautionary steps were taken to reduce possible mycoplasma and other contamination: the pre-banked cells were propagated in plasmocin (Invivogen, San Diego, CA) containing growth media for two weeks, followed by two weeks in the absence of antibiotics to determine whether fast-growing microbial contaminants were present or abnormal morphological changes would occur. The cells were confirmed negative by PCR for the presence of mycoplasma DNA using a Takara PCR Mycoplasma Detection kit (Takara Bio, USA, Thermo Fisher), and by mycoplasma tests (culture and DNA staining) performed by a commercial testing laboratory (Bionique Testing Laboratories, Saranac Lake, NY). The cell lines were observed daily to monitor confluency and checked for normal morphology. They were split when they reached ~90% confluency. Cell counts were performed on harvested cultures using either trypan blue dye-exclusion hemacytometer methodology or by automated cell size analysis (CASY 1 counter).
Actively growing MDCK and Mv1 Lu cells were planted at 1-3 × 103 viable cells/well in 96 well microtiter plates a minimum of three days prior to assay. Likewise, 6-well microtiter plates were planted at least three days prior to performing a plaque assay at a seeding density of 3-6 × 105 viable cell/well. Cell banks were prepared by freezing actively growing cells in standard growth medium containing 5% DMSO. After rapid thawing of frozen vials of cells, each vial was centrifuged, the freeze medium was discarded, and the cell pellet was resuspended in growth medium for planting culture vessels.
2. Influenza viruses
Influenza virus H5N1 strains A/Vietnam/1203/2004 and A/Mongolia/244/2005 were from archives of the Southeast Poultry Research Laboratory, and A/Iraq/207-NAMRU3/2006 was from the National Biodefense Analysis and Countermeasures Center [NBACC], which obtained the virus from Naval Medical Research Unit No. 3 [NAMRU-3], Cairo, Egypt (37) (Table 1). The H5N1 viruses were received as low-passage stocks, and their identity verified using viral genomic sequencing. Other influenza viruses were obtained from the Centers for Disease Control and Prevention or from the ATCC.
3. Virus propagation
Low-passage stocks of the H5N1 viruses were propagated in the allantoic cavities of 10-day-old embryonated chicken eggs (ECE) for 24 h at 37°C; the allantoic fluid was harvested, centrifuged for clarification, and stored at -80°C for up to one year or in the vapor phase of liquid nitrogen for longer storage [3, 11, 14, 15]. All work with H5N1 viruses was conducted in a Biosafety Level 3 enhanced laboratory. Subtype H1 and H3 influenza viruses were propagated in ECE or in MDCK cells (using the same substrate they were propagated in at the ATCC or CDC).
4. Calculation of TCID50 values
TCID50 values were determined by infecting MDCK and Mv1 Lu cells in 96-well microtiter plates with serial dilutions of virus and calculation of the TCID50 four days later by the method of Reed and Muench . Cells for TCID50 determinations were in serum-free complete EMEM containing L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin, and re-fed with the same medium. As the specific activity of the TPCK-trypsin was relatively high, the final concentrations of TPCK-trypsin were 1.0 μg/ml for MDCK cells and 0.1 μg/ml for Mv1 Lu cells.
5. Plaque assays
For plaque assays, newly confluent MDCK or Mv1 Lu cells in six-well tissue culture plates were inoculated with 0.2 ml of virus serially diluted in serum-free complete EMEM containing TPCK-treated trypsin. Virus was adsorbed to cells for 1 hr at 37ºC (H5N1) or 35 ºC (seasonal influenza viruses) with rocking every 15 min (2009 pandemic influenza H1N1 were adsorbed for 2 h at 35 ºC). After virus adsorption, the cells were washed with serum-free EMEM and the wells overlaid with 3 ml/well of primary overlay consisting of 1.6% w/v agarose (Invitrogen Corp.) mixed 1:1 with serum-free 2X EMEM (Lonza, Walkersville, MD) containing antibiotics and TPCK-trypsin. With the exception of H1N1 pandemic influenza 2009 viruses, plates were inverted and incubated for 3 days at temperatures appropriate for the viruses, then overlaid with 2 ml of secondary overlay of 1.6% w/v agarose mixed 1:1 with 2X EMEM containing 0.14 mg/ml neutral red (catalog number N2889, Sigma-Aldrich, St. Louis, MO), the plates inverted, and incubated for two additional days to visualize plaques. The pandemic 2009 H1N1 viruses required longer incubation times: 3 days after the primary overlay (performed as described above), the cells were overlaid 2 ml/well of 1.6% w/v agarose (Invitrogen Corp.) mixed 1:1 with serum-free 2X EMEM (Lonza) containing antibiotics and TPCK-trypsin, inverted, and incubated for another 2 days. They were subsequently overlaid with 2 ml of secondary overlay with neutral red as described above, and the plates incubated for 2 additional days to visualize plaques.
Part of this work was performed at the Midwest Research Institute (MRI) in Kansas City in support of a cooperative teaming agreement between MRI and the United States Department of Agriculture together with the National Biodefense Analysis and Countermeasuures Center. The authors thank Dr. David Swayne, Southeast Poultry Research Laboratory, Agricultural Research Service, United States Department of Agriculture, Athens, Georgia, for providing two of the H5N1 strains used for this work and for helpful scientific insights and discussion. The following scientists working at NBACC provided technical input: Drs. Matthew Bender, Elizabeth Leffel (now at PharmAthene, Annapolis, MD), and Richard Kenyon. Finally, the NBACC virus acquisition team is thanked for acquiring and providing A/Iraq/207-NAMRU3/2006 (H5N1).
- Li IW, Chan KH, To KW, Wong SS, Ho PL, Lau SK, Woo PC, Tsoi HW, Chan JF, Cheng VC, Zheng BJ, Chen H, Yuen KY: Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol 2009, 46:325–330.PubMedView Article
- Schultz-Cherry S, Dybdahl-Sissoko N, McGregor M, Hinshaw VS: Mink lung epithelial cells: unique cell line that supports influenza A and B virus replication. J Clin Microbiol 1998, 36:3718–3720.PubMed
- Lednicky JA, Hamilton SB, Tuttle RS, Sosna WA, Daniels DE, Swayne DE: Ferrets develop fatal influenza after inhaling small particle aerosols of highly pathogenic avian influenza virus A/Vietnam/1203/2004 (H5N1). Virol J 2010, 7:e231.View Article
- Marcus PI, Ngunjiri JM, Sekellick MJ: Dynamics of biologically active subpopulations of influenza virus; plaque-forming, noninfectious cell-killing, and defective interfering particles. J Virol 2009, 83:8122–8130.PubMedView Article
- Marcus PI, Rojek JM, Sekellick MJ: Interferon induction and/or production and its suppression by influenza viruses. J Virol 2005, 79:2880–2890.PubMedView Article
- Nayak DP, Chambers TM, Akkina RK: Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression, and interference. Curr Top Microbiol Immunol 1985, 114:103–151.PubMed
- Ngunjiri JM, Sekellick MJ, Marcus PI: Clonogenic assay of type A influenza viruses reveals noninfectious cell-killing (apoptosis-inducing) particles. J Virol 82:2673–2680.
- Reina J, Fernandez-Baca V, Blanco I, Munar M: Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture. J Clin Microbiol 1997, 35:1900–1901.PubMed
- Schepetiuk SK, Kok T: The use of MDCK, MEK, and LLC-MK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens. J Virol Methods 1993, 42:241–250.PubMedView Article
- Swayne DE, Senne DA, Suarez DL: Avian influenza. In Isolation and Identification of Avian Pathogens. 5th edition. Edited by: Dufour-Zavala L, Swayne DE, Glisson JR, Pearson JE, Reed WM, Jackwood MW, Woolcock PR. Jacksonville, Florida: American Association of Avian Pathologists; 2008:128–134.
- World Health Organization Manual on Animal Influenza Diagnosis and Surveillance [http://www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf]
- Huang YT, Turchek BM: Mink Lung Cells and Mixed Mink Lung and A549 Cells for Rapid Detection of Influenza Virus and Other Respiratory Viruses. J Clin Microbiol 2000, 38:422–423.PubMed
- Matsuura Y, Yanagawa R, Noda H: Experimental infection of mink with influenza A viruses. Arch Virol 1979, 62:71–76.PubMedView Article
- Hamilton SB, Daniels DE, Sosna WA, Jeppesen ER, Owells JM, Halpern MD, McCurdy KS, Rayner JO, Lednicky JA: Gas-permeable ethylene bags for the small scale cultivation of highly pathogenic avian influenza H5N1 and other viruses in embryonated chicken eggs. Virol J 2010,7(1):23.PubMedView Article
- Szretter KJ, Balish AL, Katz JM: Influenza: Propagation, quantification, and storage. In Current protocols in microbiology. Volume 1, Chapter 15. New Jersey: John Wiley & Sons, Inc; 2006:Unit 15G.1.
- Reed LJ, Muench H: A simple method for estimating fifty percent endpoints. Am J Hyg 1938, 27:493–497.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.